MDXG

MiMedx Group, Inc.

MiMedx Group Inc is a developer, manufacturer and marketer of patent-protected regenerative biomaterial products and bioimplants processed from human amniotic membrane.

MiMedx Group, Inc. (MDXG) is scored daily on Deltasharpe Prism against Healthcare sector peers across five pillars: Value, Growth, Profitability, Momentum and Revisions.

Quantitative Factor Evaluation • Updated

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-13 B- (2.9) C+ (2.7) B (3.3) B- (2.9) C+ (2.6) B- (2.9)
2026-11-06 B- (2.9) C+ (2.7) B (3.3) C+ (2.7) C+ (2.7) B- (2.9)
2026-10-30 C+ (2.6) C+ (2.7) B (3.4) B- (3.1) C+ (2.7) B- (2.9)
2026-10-23 C- (2.1) C+ (2.7) B (3.4) B- (3.0) C+ (2.6) C+ (2.8)

Showing the last month only. Subscribe for the full factor score history.

For more — Subscribe